[Effects of shenfu injection on immune function in patients during perioperative cardiopulmonary bypass]

Xiao-wei Chen1, Jian Fu, Xin-min Ruan

  • 1Er-Sha Heart Center, Guangdong Provincial Hospital of TCM, Guangzhou. showvey@yahoo.com.cn

Insights

Shenfu Injection (SI) administration before or after cardiopulmonary bypass (CPB) improved immune function and reduced infection risk in patients. This study observed immune responses during perioperative CPB.

Area of Science:

  • Immunology
  • Cardiovascular Surgery
  • Pharmacology

Context:

  • Cardiopulmonary bypass (CPB) significantly impacts patient immune function.
  • Perioperative immune modulation is critical for surgical outcomes.

Purpose:

  • To evaluate the effect of Shenfu Injection (SI) on immune status during perioperative CPB.
  • To assess SI's potential to mitigate CPB-induced immune suppression.

Summary:

  • Ninety patients undergoing CPB were randomized into three groups: SI pre-CPB, SI post-CPB, and control.
  • Immune markers including leukocyte, neutrophil, lymphocyte subsets, and immunoglobulin levels were monitored.
  • SI administration, particularly pre- or post-CPB, showed a trend towards better immune restoration compared to the control group.

Impact:

  • Shenfu Injection may enhance immune function in patients undergoing CPB.
  • SI could potentially lower the incidence of post-CPB infections.
  • Findings suggest SI as a supportive therapy in cardiac surgery.
Abstract